Dr. Anton Bizzell on MSNBC from The Bizzell Group on Vimeo.
Dr. Anton Bizzell, CEO of The Bizzell Group (Bizzell) asks Luvleen Sidhu, co-founder, president and chief strategy officer at BankMobile, what are some effective ways to market to different age groups like millennials and Baby Boomers.
In recognition of his extensive expertise in substance abuse prevention and treatment, Anton Bizzell, M.D., CEO of The Bizzell Group (Bizzell), has been appointed by the Secretary of the U.S. Department of Health and Human Services (HHS) to serve on the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) National Advisory Council. Dr. Bizzell’s appointment is effective through November 2018.
CSAP leads the development of national substance abuse prevention policies and programming, promotes the adoption of proven, science-based substance abuse prevention approaches and helps states and communities build their capacity to implement these approaches. As a member of the CSAP National Advisory Council, Dr. Bizzell will support this mission by making recommendations on agency and center activities and policies, in addition to reviewing grant and cooperative agreement submissions. “It’s a great honor and responsibility to work at a national level to help states and communities find proven and practical ways to prevent substance abuse and reduce the impact this disease has on individuals, families and communities,” said Dr. Bizzell.
Since earning his Doctorate in Medicine from the University of Virginia, Dr. Bizzell has spent the majority of his career working to improve access and quality of care issues for people experiencing substance abuse, mental illness or complicating health issues. He has more than 20 years of combined clinical, research, health services, policy and management experiences with various private and public organizations, including his service as a Medical Officer at both the National Institute on Alcohol Abuse and Alcoholism, NIH, and the Center for Substance Abuse Treatment, SAMHSA. Dr. Bizzell has also provided leadership to projects of national significance including CSAP’s Prevention Fellowship Program, SAMHSA’s Federal Drug Free Workplace Technical Support contract, and SAMHSA’s Prescription Drug Misuse and Abuse project.
Anton Bizzell, M.D., CEO of The Bizzell Group (Bizzell) celebrates the publication of the fifth edition of The ASAM Principles of Addiction Medicine. The publication is the go-to textbook in the specialty field of addiction medicine, with the fifth edition providing core knowledge by “blending scientific principles underlying addiction with the practical essential of clinical addiction medicine.” The chapter, Ethical Issues in Addiction Practice was co-authored by Dr. Bizzell, H. Westley Clark, MD, JD, MPH, CAS, FASAM and Anthony Campbell, RPh, DO.
Dr. Bizzell brings significant experience within the health care community having served as a medical officer for the Substance Abuse and Mental Health Services Administration (SAMHSA) and with the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The chapter itself, details core ethical principles, aspects of dealing with denial, establishing an ethical stance, and potential future developments that could stimulate unprecedented paradigm shifts that may influence health care decision-making that would impact the disenfranchisement underlying health disparities in addiction treatment.
“It’s always an honor to be asked to participate in developing a narrative for something I’ve always been very passionate about,” Dr. Bizzell said in a statement. “Its one thing to manage programs and work with people addressing addictive behaviors nationwide, but to be able to contribute to the field, and educate others is equally as rewarding. “
The ASAM Principles of Addiction Medicine Fifth Edition may be ordered through the publisher Lippincott Williams & Wilkins and includes a fully searchable online app version of the text and appendices and review questions. Phone orders dial 1-800-638-3030.
The Coalition on Physician Education in Substance Use Disorders’ (COPE) Executive Committee recently announced the appointment of Anton C. Bizzell, M.D., CEO of The Bizzell Group (Bizzell), to COPE’s governing body. The designation adds to Dr. Bizzell’s rich history in the field of health education as he has served as a Medical Officer with the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as in the Office of Translational Research and Education at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), providing support for research and educational projects addressing physician and other allied health professions’ continuing education.
COPE was formed in 2010 to sustain and expand on the accomplishments of a series of White House Conferences on Medical Education in Substance Abuse, sponsored in 2003, 2006, and 2009 by the Office of National Drug Control Policy in the Executive Office of the President. The organization’s overarching goal is to improve the education of medical students in the areas of alcohol, tobacco and other drug use disorders – ranging from problematic or risky use to addiction. Another goal is to help medical students receive appropriate training to develop the skills they need to prevent, screen for, diagnose and manage substance use disorders in their patients, regardless of the location or specialty in which they ultimately practice.
As a member of COPE’s governing body Dr. Bizzell will have a hand in supporting the organization’s current activities including administration of medical school surveys and sponsorship of regional Medical Education Summits which are designed to identify specific needs and respond to opportunities for enhancing teaching about substance use disorders in the undergraduate years. COPE also produces an e-newsletter, which is distributed to more than 3,000 readers, and maintains a website that offer news and resources to medical educators.
To learn more about COPE visit: www.cope-assn.org.